Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05400122
Title Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Jennifer Eva Selfridge
Indications

chronic lymphocytic leukemia

acute lymphoblastic leukemia

indolent plasma cell myeloma

acute myeloid leukemia

rectum adenocarcinoma

myelodysplastic syndrome

non-Hodgkin lymphoma

colon adenocarcinoma

chronic myeloid leukemia

Hodgkin's lymphoma

myeloproliferative neoplasm

Therapies

Aldesleukin + TEW 7197

Cyclophosphamide + Fludarabine

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.